Related Experiment Video

Updated: Jul 11, 2026

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence

Frédérick A Mallette1, Marie-France Gaumont-Leclerc, Geneviève Huot

  • 1Département de Biochimie, Université de Montréal, Montréal, Québec H3C 3J7, Canada.

The Journal of Biological Chemistry
|October 5, 2007
PubMed

Insights

Constitutively active STAT5A induces cellular senescence via p53 and Rb pathways, distinct from known mechanisms. This STAT5A-induced senescence involves Myc downregulation and bypasses p21/p16(INK4a) pathways.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • Cellular senescence is a crucial tumor suppressor mechanism preventing proliferation of cells with oncogenic mutations.
  • The p53 and Retinoblastoma (Rb) pathways are key regulators of senescence, often activated by oncogene-induced stress.
  • Specific oncogenes can trigger senescence through diverse molecular pathways, highlighting context-dependent regulation.

Purpose of the Study:

  • To investigate the mechanism by which constitutively active STAT5A (ca-STAT5A) induces cellular senescence.
  • To determine if ca-STAT5A-induced senescence utilizes canonical senescence-associated genes like p21 and p16(INK4a).
  • To elucidate the role of Myc and its downstream targets in STAT5A-mediated senescence.

Main Methods:

  • Induction of senescence using constitutively active STAT5A in cell culture models.
  • Analysis of p53, Rb, p21, p16(INK4a), Myc, and CDK4 expression and activity.
  • Investigation of Myc protein stability and localization using proteasome inhibitors and microscopy.
  • Functional assays involving ectopic expression of CDK4 or Myc to bypass senescence.

Main Results:

  • Constitutively active STAT5A induced p53- and Rb-dependent cellular senescence.
  • STAT5A-induced senescence occurred independently of p21 and p16(INK4a) upregulation.
  • ca-STAT5A caused downregulation of Myc and its targets, including CDK4, in a proteasome-dependent manner.
  • Myc downregulation correlated with its localization to promyelocytic leukemia bodies during senescence.
  • Overexpression of CDK4 or Myc could bypass STAT5A-induced senescence in p53-inactivated cells.

Conclusions:

  • Constitutively active STAT5A engages the Rb pathway through a novel mechanism involving Myc downregulation, distinct from canonical senescence pathways.
  • This study reveals oncogene-specific pathways regulating senescence, expanding our understanding of tumor suppression.
  • STAT5A-induced senescence offers a new model for studying the complex interplay between oncogenes and cell cycle control.

More Related Videos

Techniques to Induce and Quantify Cellular Senescence06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...